Marrone Bio Innovations Inc (MBII): Pamela G Marrone , CEO of Marrone Bio Innovations Inc purchased 5,000 shares on Jun 6, 2016. The Insider buying transaction was reported by the company on Jun 13, 2016 to the Securities and Exchange Commission. The shares were purchased at $0.69 per share for a total value of $3,460.00 , the company said in a SEC Form 4 Filing.
Marrone Bio Innovations Inc: On Friday, Jun 10, 2016 heightened volatility was witnessed in Marrone Bio Innovations Inc which led to swings in the share price. The shares opened for trading at $0.74 and hit $0.86 on the upside , eventually ending the session at $0.799, with a gain of 7.97% or 0.059 points. The heightened volatility saw the trading volume jump to 7,32,707 shares. The 52-week high of the share price is $4 and the company has a market cap of $20 M . The 52-week low of the share price is at $0.6013.
Company has been under the radar of several Street Analysts.Marrone Bio Innovations Inc is Initiated by Rodman & Renshaw to Buy and the brokerage firm has set the Price Target at $3.50. The Rating was issued on Mar 16, 2016.
Marrone Bio Innovations Inc. is a provider of bio-based pest management and plant health products. Bio-based products are consists of naturally occurring microorganisms such as bacteria and fungi and plant extracts. As of August 1 2013 the Companys three commercialized product lines target two core end markets: crop protection and water treatment. Crop protection products consist of herbicides fungicides nematicides insecticides and plant growth regulators that growers use to increase crop yields improve plant health manage pest resistance and reduce chemical residues. The Companys products can be used in both conventional and organic crop production. The Company sells two crop protection product lines Regalia for plant disease control and plant health and Grandevo for insect and mite control to growers of specialty crops such as grapes citrus tomatoes vegetables nuts leafy greens and ornamental plants.